--- title: 'Scientist, Analytical Development at Aspect Biosystems' canonical: 'https://feeny.ai/job/scientist-analytical-development-aspect-biosystems-vancouver-xd1fs7rs1gm8' type: 'job' last_seen: '2026-09-18' --- # Scientist, Analytical Development at Aspect Biosystems - **Company:** Aspect Biosystems - **Location:** Vancouver, Canada - **Work type:** onsite - **Posted:** 2026-09-14 - **Last confirmed live:** 2026-09-18 - **Apply:** https://job-boards.greenhouse.io/aspectbiosystems/jobs/5415955008 ## Job description We're looking for a Scientist, Analytical Development to join our technical operations team. In this role, you'll be instrumental in developing, optimizing, and qualifying analytical methods that support our cutting-edge bioprinted tissue therapeutics. Reporting to our Head, Quality Control and Analytical Development, you'll play a crucial part in ensuring the quality and characterization of our innovative products as we advance toward clinical development. ## Responsibilities - Design, execute, and optimize a variety of analytical methods (e.g. cell-based assays, bioanalytical and flow cytometry methods) for the characterization, release, and stability testing of raw materials, in-process samples, and final drug products. - Participate in and execute experiments for the qualification and validation of analytical methods in accordance with phase-appropriate regulatory guidelines (e.g., ICH, FDA, Health Canada, EMA). - Perform routine analytical testing as needed to support process development, product characterization, and early-stage stability studies. - Accurately record, analyze, interpret, and present experimental data. Author and review technical reports, study protocols, and standard operating procedures (SOPs) in compliance with GxP principles. - Identify and troubleshoot analytical method issues, propose solutions, and implement corrective actions. - Work cross functionally with Process Development, Quality Control, Research & Development, and Manufacturing to support product development milestones and resolve analytical challenges. - Perform routine maintenance and calibration of analytical instruments and ensure proper functioning. - Adhere to and contribute to the development of robust analytical quality systems, ensuring data integrity, traceability, and compliance with internal and external regulations. ## Qualifications & Experience - Education & Experience: Bachelor's or Master's degree in a relevant scientific discipline with 3-5 years of relevant experience in analytical development within the biotechnology or pharmaceutical industry with hands-on experience in cell therapy, gene therapy, or combination products. - Analytical Expertise: Proven hands-on experience with a range of analytical techniques, such as flow cytometry, ELISA, and/or cell-based assays. - GxP Knowledge: Familiarity with GxP principles (GLP, GMP) and an understanding of regulatory expectations for analytical method development, qualification, and validation for biologics or advanced therapies. - Problem-Solver: You have a keen eye for detail and a methodical approach to troubleshooting analytical challenges. - Innovation Mindset: You're eager to learn new techniques and contribute to the continuous improvement of analytical processes. The hiring range for this role is $90,000 - $96,300, annually. Our pay scales are based on market data to ensure that compensation is competitive and fair. Offered salaries will be based on a combination of factors including, but not limited to, job-related knowledge, skills, education, and experience. For candidates who exceed role requirements, we are open to exploring above-range offers. Base salary is just one part of the overall compensation at Aspect, team members also receive equity, a comprehensive benefits package, and support for continuous learning and career progression. ## Who We Are Aspect Biosystems is a biotechnology company pioneering the development of a novel category of regenerative medicine designed to restore or supplement biological function and deliver curative therapies for some of the most elusive diseases. Aspect is developing these bioengineered cellular medicines by applying its full-stack tissue therapeutic platform, which integrates proprietary AI-powered bioprinting technology, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. Aspect is advancing its therapeutic pipeline across multiple endocrine and metabolic diseases, including diabetes and rare endocrine disorders. If you are committed to making a real impact and accelerating the development of life-changing therapies, we want to hear from you! Curious about our current perks and benefits? Learn more [here](https://aspectbiosystems.com/careers). At Aspect Biosystems, our strength has always been in our diversity. Different people, thinking differently, unified in creating a world that is better for us all. We are committed to creating an inclusive environment for everyone on our team. All aspects of employment — including the decision to hire, promote, discipline, or terminate — are based on merit, competence, performance, and business needs. We do not discriminate on the basis of race, color, religion, citizenship status, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, political affiliation, or any other status protected under federal, state, provincial, or local law. If you're interested in joining our team but don't see a job posting that matches your experience or background, we encourage you to [submit a general application](https://boards.greenhouse.io/aspectbiosystems/jobs/4009049008) to be considered for future opportunities! ## About Aspect Biosystems ## Company Overview - **One-liner**: Aspect Biosystems is a Canadian biotechnology company pioneering the development of Bioprinted Tissue Therapeutics—implantable, bioengineered cellular medicines designed to replace, repair, or supplement biological function to treat incurable diseases. - **Entity Type**: Private (Series Unknown; raised US$350M+ in total capital) - **Headquarters**: Vancouver, British Columbia, Canada - **Founded**: 2013 - **Founders**: Tamer Mohamed (CEO), Simon Beyer (CTO), Sam Wadsworth (CSO) ## Core Business - **Primary Industry**: Biotechnology / Regenerative Medicine / Tissue Engineering - **Target Customers**: B2B (pharmaceutical and biotech partners for co-development and clinical trials), and ultimately B2B2C (patients with metabolic and endocrine diseases such as diabetes). - **Mission**: To develop Bioprinted Tissue Therapeutics that replace, repair, or supplement biological function, transforming the treatment of incurable diseases. ## Products & Services - **Bioprinted Tissue Therapeutics (Pipeline)**: Implantable, allogeneic tissues designed to treat metabolic and endocrine diseases (e.g., diabetes, rare endocrine disorders). These are bioengineered cellular medicines that integrate proprietary AI-powered bioprinting, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials. - **Full-Stack Tissue Therapeutic Platform**: A vertically integrated technology stack that includes AI-powered bioprinting systems, microfluidic printheads, lab automation, software, machine learning, and computational design tools. This platform is used for internal pipeline development and partnered programs. - **Partnerships (Co-Development)**: Collaborates with pharmaceutical and biotech leaders (e.g., Novo Nordisk) to bring cutting-edge cell therapies to the clinic, leveraging its platform for co-development. ## Market Standing - **Valuation/Market Cap**: Not publicly disclosed. - **Key Metric**: Total funding raised is over US$350M (including a US$280M partnership with the Government of Canada announced in 2026, a US$115M round in 2024, and a US$72.75M government investment in 2024). LinkedIn reports total funding at US$278.7M. - **Notable Investors/Partners**: Novo Nordisk (major pharma partner), Government of Canada (major strategic partner), Western Innovation (WINN) Initiative, entrepreneurship@UBC. - **Growth Signals**: Headcount grew 26.5% YoY to 116 employees. Announced a new phase of partnership with Novo Nordisk in January 2026. Secured a US$280M partnership with the Government of Canada in April 2026. Won multiple awards including Life Sciences BC Company of the Year 2024 and BIOTECanada Biotech Company of the Year. ## Competitive Advantages - **Full-Stack Platform**: Integrates proprietary AI-powered bioprinting, therapeutic cells, hypoimmune cell engineering, and advanced biomaterials—a vertically integrated approach that is difficult to replicate. - **Strategic Partnerships**: Deep, multi-phase partnership with Novo Nordisk, a global leader in diabetes care, providing validation, funding, and clinical development expertise. - **Government Support**: Significant non-dilutive funding and strategic backing from the Government of Canada (US$280M partnership), providing a strong financial runway and national-level support. - **Experienced Leadership Team**: Leadership includes executives with deep experience from Vertex Pharmaceuticals, Novo Nordisk, BlueRock Therapeutics (Bayer), and ViaCyte (Vertex), bringing proven expertise in advancing cell therapies from research to late-stage clinical development. ## Strategic Focus - **Clinical Translation**: Advancing its pipeline of Bioprinted Tissue Therapeutics toward first-in-human clinical trials, with a strong focus on diabetes and rare endocrine disorders. - **Platform Expansion**: Continuing to develop and vertically integrate its full-stack tissue therapeutic platform (AI bioprinting, cell engineering, biomaterials) to enable a broad pipeline of therapies. - **Strategic Partnerships**: Deepening its collaboration with Novo Nordisk to develop curative medicines for diabetes, and seeking additional pharma/biotech partners to leverage its platform for other indications. - **Manufacturing & Scale-Up**: Building out technical operations, process development, and manufacturing capabilities to support clinical translation and eventual commercialization. ## Why Work Here - **Mission-Driven Work**: Employees are directly contributing to developing transformative, curative therapies for incurable diseases, with a strong sense of purpose and impact. - **Culture & Values**: Described as supportive, collaborative, and intellectually curious. The team is interdisciplinary (scientists, engineers, entrepreneurs) and globally diverse. - **Compensation & Benefits**: Competitive salary, stock options, fully paid extended healthcare for employee and family, life insurance, AD&D, parental leave top-up, annual professional development allowance, health & wellness spending account. - **Work-Life Balance**: Minimum 3 weeks' vacation plus a December holiday break, flexible work hours. - **Work Environment**: On-site roles in Vancouver, BC. Office features collaboration spaces, board games, video games, employee-led groups (book club), nearby walking/cycling routes, underground bike cages, and on-site showers. - **Culture**: Described as supportive, collaborative, intellectually curious, and mission-driven. Employees report feeling they make a meaningful impact. The team is interdisciplinary and globally diverse. - **Recognition**: Named one of Canada's Best Employers for Recent Graduates, Life Sciences BC Company of the Year 2024, BIOTECanada Biotech Company of the Year, and Fast Company Next Big Things in Tech. ## Sources 1. [aspectbiosystems.com](https://www.aspectbiosystems.com/) 2. [aspectbiosystems.com/about](https://aspectbiosystems.com/about) 3. [aspectbiosystems.com/careers](https://aspectbiosystems.com/careers) 4. [job-boards.greenhouse.io/aspectbiosystems](http://job-boards.greenhouse.io/aspectbiosystems) 5. [linkedin.com/company/aspect-biosystems](https://ca.linkedin.com/company/aspect-biosystems) ## Other roles at Aspect Biosystems - [Director, Clinical Operations](https://feeny.ai/job/director-clinical-operations-aspect-biosystems-vancouver-7m94smmk3132) — Vancouver, Canada - [Procurement Specialist](https://feeny.ai/job/procurement-specialist-aspect-biosystems-vancouver-9rpfgdhyvhnk) — Vancouver, Canada - [Quality Assurance Specialist](https://feeny.ai/job/quality-assurance-specialist-aspect-biosystems-vancouver-7mta1vv2hgk0) — Vancouver, Canada - [Senior Process Engineer (12 Month Contract)](https://feeny.ai/job/senior-process-engineer-12-month-contract-aspect-biosystems-vancouver-7w6pzvbsbr3p) — Vancouver, Canada - [Associate Process Engineer (12 month contract)](https://feeny.ai/job/associate-process-engineer-12-month-contract-aspect-biosystems-vancouver-vqs5c9teynn2) — Vancouver, Canada - [Associate, Process Development (Cells)](https://feeny.ai/job/associate-process-development-cells-aspect-biosystems-vancouver-dnarb66fc5q4) — Vancouver, Canada - [Scientist, Quality Control & Analytical Development](https://feeny.ai/job/scientist-quality-control-analytical-development-aspect-biosystems-fremont-9dpb6ccq0d4r) — Fremont, CA - [Head of Quality Assurance](https://feeny.ai/job/head-of-quality-assurance-aspect-biosystems-fremont-f3b8zjr40w1t) — Fremont, CA - [Manufacturing Technician](https://feeny.ai/job/manufacturing-technician-aspect-biosystems-fremont-zgfry24v70h9) — Fremont, CA - [General Application](https://feeny.ai/job/general-application-aspect-biosystems-vancouver-kqv4f0g8qc6h) — Vancouver, Canada